Dapoxetine: a guide to its use in premature ejaculation
Drugs & Therapy Perspectives,  Clinical Article

Dapoxetine, a selective serotonin reuptake inhibitor, is indicated for the treatment of premature ejaculation in men aged 18–64 years. In well designed clinical trials in men with premature ejaculation, treatment with dapoxetine significantly increased intravaginal ejaculation latency times relative to placebo and was generally well tolerated.

Please login or register to follow this author.
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

    Currently, there are no available articles.

Your Unread Messages in Urology

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Urology Articles

Indexed Journals in Urology: Urology, Journal of Urology, European Urology, The Prostatemore